Related Experiment Videos

Change in mortality from coronary heart disease and stroke in Arkansas (1979 to 2007)

Appathurai Balamurugan1, Paulette Mehta, Joseph Bates

  • 1Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, USA.

Insights

Mortality from coronary heart disease (CHD) and stroke decreased significantly in Arkansas from 1979 to 2007. Declining cigarette smoking rates appear to be a key factor, despite rising obesity and diabetes.

Area of Science:

  • Public Health and Epidemiology
  • Cardiovascular Disease Research

Background:

  • Southern states historically exhibit higher coronary heart disease (CHD) and stroke mortality rates compared to the rest of the US.
  • While national CHD and stroke mortality have declined over three decades, the trend in Southern states remained unclear.

Purpose of the Study:

  • To investigate CHD and stroke mortality trends in Arkansas from 1979 to 2007.
  • To explore potential contributing factors to observed mortality changes in the region.

Main Methods:

  • Analysis of CHD and stroke-related death records in Arkansas between 1979 and 2007.
  • Examination of concurrent trends in obesity, hypertension, diabetes mellitus, physical inactivity, poverty, and per capita cigarette sales.

Main Results:

  • Observed a marked and steady decrease in both CHD and stroke death rates in Arkansas during the study period.
  • Concurrent increase in obesity, hypertension, and diabetes mellitus prevalence, alongside decreased physical inactivity and poverty.
  • A significant decrease in per capita cigarette sales closely paralleled the decline in CHD and stroke mortality.

Conclusions:

  • While cardioprotective drugs and revascularization may have contributed, reduced cigarette smoking is strongly suggested as a primary driver of decreased CHD and stroke mortality in Arkansas.
  • This study highlights the significant public health impact of smoking cessation on cardiovascular and cerebrovascular disease outcomes in a historically high-mortality region.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...